News
Video
Managing AEs in Cabo Nivo Combination Therapy for Advanced RCC
Author(s):
Expert oncologists discuss the nuances of managing toxicities associated with Cabozantinib and Nivolumab combination therapy for advanced renal cell carcinoma (RCC).
EP: 1.Overview on Advanced RCC: Epidemiology, Presentation, and Risk Stratification
EP: 2.Frontline Therapy for Advanced Renal Cell Carcinoma: Patient Scenario Discussion
EP: 3.Imaging and Staging Considerations in Renal Cell Carcinoma
EP: 4.Frontline Therapy for Renal Cell Carcinoma: Choosing the Right Regimen
EP: 5.Treatment Strategies for Non-Clear Cell Renal Cell Carcinoma
EP: 6.Comparing Treatment Combinations in Renal Cell Carcinoma
EP: 7.Key Decision Factors in Selecting Frontline Therapy for Metastatic RCC
EP: 8.Sequencing and Second-Line Therapy in RCC: Patient Scenario
Now Viewing
EP: 9.Managing AEs in Cabo Nivo Combination Therapy for Advanced RCC
EP: 10.Navigating Toxicity Discussions With Patients With Renal Cell Carcinoma
EP: 11.Novel Therapies for Advanced RCC: LITESPARK-005 and Treatment Sequencing
EP: 12.Triple Combination Therapies in RCC: Clinical Trial Insights
EP: 13.Key Takeaways: Advancements and Challenges in Kidney Cancer Treatment
Related Videos
Related Content
